1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. Key Offerings
1.2. Market Segmentation
1.3. Research Methodology
1.3.1. Phase I - Secondary Research
1.3.2. Phase II - Primary Research
1.3.3. Phase III - Expert Panel Review
1.3.4. Assumptions
1.3.5. Approach Adopted

2. Executive Summary
2.1. Market Snapshot: Global Dental Biomaterials Market
2.2. Global Dental Biomaterials Market, By Biomaterial, 2023 (US$ Million)
2.3. Global Dental Biomaterials Market, By End-User, 2023 (US$ Million)
2.4. Global Dental Biomaterials Market, By Geography, 2023 (US$ Million)
2.5. Attractive Investment Proposition by Geography, 2023

3. Dental Biomaterials Market: Competitive Analysis
3.1. Market Positioning of Key Dental Biomaterials Market Vendors
3.2. Strategies Adopted by Dental Biomaterials Market Vendors
3.3. Key Industry Strategies
4. Dental Biomaterials Market: Macro Analysis & Market Dynamics
4.1. Introduction
4.2. Global Dental Biomaterials Market Value, 2022 - 2032, (US$ Million)
4.3. Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Key Challenges
4.3.4. Key Opportunities
4.4. Impact Analysis of Drivers and Restraints
4.5. See-Saw Analysis
4.6. Porter's Five Force Model
4.6.1. Supplier Power
4.6.2. Buyer Power
4.6.3. Threat Of Substitutes
4.6.4. Threat Of New Entrants
4.6.5. Competitive Rivalry
4.7. PESTEL Analysis
4.7.1. Political Landscape
4.7.2. Economic Landscape
4.7.3. Technology Landscape
4.7.4. Legal Landscape
4.7.5. Social Landscape

5. Dental Biomaterials Market: By Biomaterial, 2022-2032, USD (Million)
5.1. Market Overview
5.2. Growth & Revenue Analysis: 2023 Versus 2032
5.3. Market Segmentation
5.3.1. Metallic Biomaterials
5.3.1.1. Titanium
5.3.1.2. Stainless Steel
5.3.1.3. Chromium Alloys
5.3.1.4. Other Metallic Materials (Gold, Nickel, etc.)
5.3.2. Ceramic Biomaterials
5.3.2.1. Silica - based Ceramics
5.3.2.2. Glass-Ceramics
5.3.2.3. High Strength Core Ceramics
5.3.3. Polymeric Biomaterials
5.3.3.1. Polyethylene (PE)
5.3.3.2. Polymethyl Methacrylate (PMMA)
5.3.3.3. Polycarbonate (PC)
5.3.3.4. Polyethylene Glycol (PEG)
5.3.3.5. Polyurethane (PUR)
5.3.3.6. Other Polymers (PLLA, PCL, Ppy, etc.)
5.3.4. Metal-Ceramic Biomaterials
5.3.5. Natural Biomaterials
5.3.6. Macular Degeneration
5.3.7. Diabetic Retinopathy
5.3.8. Retinal Vein Occlusions
5.3.9. Endophthalmitis
5.3.10. Others

6. Dental Biomaterials Market: By End-User, 2022-2032, USD (Million)
6.1. Market Overview
6.2. Growth & Revenue Analysis: 2023 Versus 2032
6.3. Market Segmentation
6.3.1. Dental Hospitals & Clinics
6.3.2. Dental Academics & Research Institutes


7. North America Dental Biomaterials Market, 2022-2032, USD (Million)
7.1. Market Overview
7.2. Dental Biomaterials Market: By Biomaterial, 2022-2032, USD (Million)
7.3. Dental Biomaterials Market: By End-User, 2022-2032, USD (Million)
7.4.Dental Biomaterials Market: By Region, 2022-2032, USD (Million)
7.4.1.North America
7.4.1.1. U.S.
7.4.1.1.1. Dental Biomaterials Market: By Biomaterial, 2022-2032, USD (Million)
7.4.1.1.2. Dental Biomaterials Market: By End-User, 2022-2032, USD (Million)
7.4.1.2. Canada
7.4.1.2.1. Dental Biomaterials Market: By Biomaterial, 2022-2032, USD (Million)
7.4.1.2.2. Dental Biomaterials Market: By End-User, 2022-2032, USD (Million)
7.4.1.3. Rest of North America
7.4.1.3.1. Dental Biomaterials Market: By Biomaterial, 2022-2032, USD (Million)
7.4.1.3.2. Dental Biomaterials Market: By End-User, 2022-2032, USD (Million)

8. UK and European Union Dental Biomaterials Market, 2022-2032, USD (Million)
8.1. Market Overview
8.2. Dental Biomaterials Market: By Biomaterial, 2022-2032, USD (Million)
8.3. Dental Biomaterials Market: By End-User, 2022-2032, USD (Million)
8.4.Dental Biomaterials Market: By Region, 2022-2032, USD (Million)
8.4.1.UK and European Union
8.4.1.1. UK
8.4.1.1.1. Dental Biomaterials Market: By Biomaterial, 2022-2032, USD (Million)
8.4.1.1.2. Dental Biomaterials Market: By End-User, 2022-2032, USD (Million)
8.4.1.2. Germany
8.4.1.2.1. Dental Biomaterials Market: By Biomaterial, 2022-2032, USD (Million)
8.4.1.2.2. Dental Biomaterials Market: By End-User, 2022-2032, USD (Million)
8.4.1.3. Spain
8.4.1.3.1. Dental Biomaterials Market: By Biomaterial, 2022-2032, USD (Million)
8.4.1.3.2. Dental Biomaterials Market: By End-User, 2022-2032, USD (Million)
8.4.1.4. Italy
8.4.1.4.1. Dental Biomaterials Market: By Biomaterial, 2022-2032, USD (Million)
8.4.1.4.2. Dental Biomaterials Market: By End-User, 2022-2032, USD (Million)
8.4.1.5. France
8.4.1.5.1. Dental Biomaterials Market: By Biomaterial, 2022-2032, USD (Million)
8.4.1.5.2. Dental Biomaterials Market: By End-User, 2022-2032, USD (Million)
8.4.1.6. Rest of Europe
8.4.1.6.1. Dental Biomaterials Market: By Biomaterial, 2022-2032, USD (Million)
8.4.1.6.2. Dental Biomaterials Market: By End-User, 2022-2032, USD (Million)

9. Asia Pacific Dental Biomaterials Market, 2022-2032, USD (Million)
9.1. Market Overview
9.2. Dental Biomaterials Market: By Biomaterial, 2022-2032, USD (Million)
9.3. Dental Biomaterials Market: By End-User, 2022-2032, USD (Million)
9.4.Dental Biomaterials Market: By Region, 2022-2032, USD (Million)
9.4.1.Asia Pacific
9.4.1.1. China
9.4.1.1.1. Dental Biomaterials Market: By Biomaterial, 2022-2032, USD (Million)
9.4.1.1.2. Dental Biomaterials Market: By End-User, 2022-2032, USD (Million)
9.4.1.2. Japan
9.4.1.2.1. Dental Biomaterials Market: By Biomaterial, 2022-2032, USD (Million)
9.4.1.2.2. Dental Biomaterials Market: By End-User, 2022-2032, USD (Million)
9.4.1.3. India
9.4.1.3.1. Dental Biomaterials Market: By Biomaterial, 2022-2032, USD (Million)
9.4.1.3.2. Dental Biomaterials Market: By End-User, 2022-2032, USD (Million)
9.4.1.4. Australia
9.4.1.4.1. Dental Biomaterials Market: By Biomaterial, 2022-2032, USD (Million)
9.4.1.4.2. Dental Biomaterials Market: By End-User, 2022-2032, USD (Million)
9.4.1.5. South Korea
9.4.1.5.1. Dental Biomaterials Market: By Biomaterial, 2022-2032, USD (Million)
9.4.1.5.2. Dental Biomaterials Market: By End-User, 2022-2032, USD (Million)
9.4.1.6. Rest of Asia Pacific
9.4.1.6.1. Dental Biomaterials Market: By Biomaterial, 2022-2032, USD (Million)
9.4.1.6.2. Dental Biomaterials Market: By End-User, 2022-2032, USD (Million)

10. Latin America Dental Biomaterials Market, 2022-2032, USD (Million)
10.1. Market Overview
10.2. Dental Biomaterials Market: By Biomaterial, 2022-2032, USD (Million)
10.3. Dental Biomaterials Market: By End-User, 2022-2032, USD (Million)
10.4.Dental Biomaterials Market: By Region, 2022-2032, USD (Million)
10.4.1.Latin America
10.4.1.1. Brazil
10.4.1.1.1. Dental Biomaterials Market: By Biomaterial, 2022-2032, USD (Million)
10.4.1.1.2. Dental Biomaterials Market: By End-User, 2022-2032, USD (Million)
10.4.1.2. Mexico
10.4.1.2.1. Dental Biomaterials Market: By Biomaterial, 2022-2032, USD (Million)
10.4.1.2.2. Dental Biomaterials Market: By End-User, 2022-2032, USD (Million)
10.4.1.3. Rest of Latin America
10.4.1.3.1. Dental Biomaterials Market: By Biomaterial, 2022-2032, USD (Million)
10.4.1.3.2. Dental Biomaterials Market: By End-User, 2022-2032, USD (Million)

11. Middle East and Africa Dental Biomaterials Market, 2022-2032, USD (Million)
11.1. Market Overview
11.2. Dental Biomaterials Market: By Biomaterial, 2022-2032, USD (Million)
11.3. Dental Biomaterials Market: By End-User, 2022-2032, USD (Million)
11.4.Dental Biomaterials Market: By Region, 2022-2032, USD (Million)
11.4.1.Middle East and Africa
11.4.1.1. GCC
11.4.1.1.1. Dental Biomaterials Market: By Biomaterial, 2022-2032, USD (Million)
11.4.1.1.2. Dental Biomaterials Market: By End-User, 2022-2032, USD (Million)
11.4.1.2. Africa
11.4.1.2.1. Dental Biomaterials Market: By Biomaterial, 2022-2032, USD (Million)
11.4.1.2.2. Dental Biomaterials Market: By End-User, 2022-2032, USD (Million)
11.4.1.3. Rest of Middle East and Africa
11.4.1.3.1. Dental Biomaterials Market: By Biomaterial, 2022-2032, USD (Million)
11.4.1.3.2. Dental Biomaterials Market: By End-User, 2022-2032, USD (Million)

12. Company Profile
12.1. Institut Straumann AG
12.1.1. Company Overview
12.1.2. Financial Performance
12.1.3. Product Portfolio
12.1.4. Strategic Initiatives
12.2. Danaher Corporation (Nobel Biocare Services AG)
12.2.1. Company Overview
12.2.2. Financial Performance
12.2.3. Product Portfolio
12.2.4. Strategic Initiatives
12.3. Geistlich Pharma AG
12.3.1. Company Overview
12.3.2. Financial Performance
12.3.3. Product Portfolio
12.3.4. Strategic Initiatives
12.4. Zimmer Biomet
12.4.1. Company Overview
12.4.2. Financial Performance
12.4.3. Product Portfolio
12.4.4. Strategic Initiatives
12.5. Biomatlante
12.5.1. Company Overview
12.5.2. Financial Performance
12.5.3. Product Portfolio
12.5.4. Strategic Initiatives
12.6. 3M
12.6.1. Company Overview
12.6.2. Financial Performance
12.6.3. Product Portfolio
12.6.4. Strategic Initiatives
12.7. Dentsply Sirona
12.7.1. Company Overview
12.7.2. Financial Performance
12.7.3. Product Portfolio
12.7.4. Strategic Initiatives
12.8. BioHorizons IPH, Inc.
12.8.1. Company Overview
12.8.2. Financial Performance
12.8.3. Product Portfolio
12.8.4. Strategic Initiatives
12.9. ACE Surgical Supply Company, Inc.
12.9.1. Company Overview
12.9.2. Financial Performance
12.9.3. Product Portfolio
12.9.4. Strategic Initiatives
12.10. Royal DSM
12.10.1. Company Overview
12.10.2. Financial Performance
12.10.3. Product Portfolio
12.10.4. Strategic Initiatives
12.11. Carpenter Technology Corporation
12.11.1. Company Overview
12.11.2. Financial Performance
12.11.3. Product Portfolio
12.11.4. Strategic Initiatives
12.12. Medtronic PLC
12.12.1. Company Overview
12.12.2. Financial Performance
12.12.3. Product Portfolio
12.12.4. Strategic Initiatives
12.13. Mitsui Chemicals, Inc.
12.13.1. Company Overview
12.13.2. Financial Performance
12.13.3. Product Portfolio
12.13.4. Strategic Initiatives
12.14. Henry Schein, Inc.
12.14.1. Company Overview
12.14.2. Financial Performance
12.14.3. Product Portfolio
12.14.4. Strategic Initiatives
12.15. Kuraray Co., Ltd.
12.15.1. Company Overview
12.15.2. Financial Performance
12.15.3. Product Portfolio
12.15.4. Strategic Initiatives